The American Gastroenterological Association (AGA) has released a comprehensive updated clinical guideline on the pharmacologic management of moderate to severe Crohn’s disease. The new guideline uses state-of-the-art network meta-analysis to recommend prescribing drugs for patients with moderate to severe Crohn’s disease based on prior treatment.
Please follow and like us:
